差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 Regeneron Pharmaceuticals, Inc. - REGN CFD

818.92
0.89%
1.04
低: 818.92
高: 830.55
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 1.04
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

Regeneron Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

“B”分數表示相對 ESG 表現良好，公開報告重要 ESG 數據的透明度高於平均水平。

關鍵數據
前收盤價* 826.3
開盤價* 830.55
1 年變化* 19.91%
日範圍* 818.92 - 830.55
52 周範圍 538.01-832.48
平均交易量（10 天） 816.08K
平均交易量（3 個月） 13.25M
市值 89.69B
市盈率 21.46
流通股 109.33M
收入 12.17B
EPS 38.24
股息（收益率 %） N/A
貝塔 0.22
下一個財報發布日期 May 2, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 28, 2023 826.30 16.39 2.02% 809.91 826.85 809.91
Mar 27, 2023 819.49 -0.34 -0.04% 819.83 831.72 812.36
Mar 24, 2023 819.63 17.38 2.17% 802.25 823.61 795.78
Mar 23, 2023 801.72 -1.10 -0.14% 802.82 811.60 787.54
Mar 22, 2023 750.68 -8.68 -1.14% 759.36 764.03 750.15
Mar 21, 2023 758.90 0.41 0.05% 758.49 764.47 750.58
Mar 20, 2023 758.21 16.55 2.23% 741.66 759.65 741.65
Mar 17, 2023 747.35 1.81 0.24% 745.54 753.70 740.70
Mar 16, 2023 748.89 -2.86 -0.38% 751.75 752.05 725.56
Mar 15, 2023 759.88 7.50 1.00% 752.38 765.58 752.38
Mar 14, 2023 766.66 13.56 1.80% 753.10 769.29 753.01
Mar 13, 2023 752.05 6.55 0.88% 745.50 768.02 740.46
Mar 10, 2023 746.30 2.75 0.37% 743.55 758.66 736.92
Mar 9, 2023 743.15 -1.92 -0.26% 745.07 755.33 738.07
Mar 8, 2023 744.62 -27.39 -3.55% 772.01 772.76 743.57
Mar 7, 2023 773.11 -7.63 -0.98% 780.74 782.86 770.56
Mar 6, 2023 779.91 5.06 0.65% 774.85 785.00 768.08
Mar 3, 2023 778.57 13.47 1.76% 765.10 779.63 764.97
Mar 2, 2023 767.91 -0.13 -0.02% 768.04 772.37 760.64
Mar 1, 2023 769.69 15.12 2.00% 754.57 772.43 754.57

Regeneron Pharmaceuticals, Inc. Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2022 2021 2020 2019 2018
總收入 12172.9 16071.7 8497.1 7863.4 6710.8
收入 12172.9 16071.7 8497.1 7863.4 6710.8
收入成本，共計 1560.4 2437.5 1119.9 782.2 434.1
毛利 10612.5 13634.2 7377.2 7081.2 6276.7
總營業費用 7434 7124.9 4920.5 5653.6 4176.4
銷售/一般/行政費用，總計 2115.9 1824.9 1346 1834.8 1556.2
研究與開發 3592.5 2908.1 2735 3036.6 2186.1
營業收入 4738.9 8946.8 3576.6 2209.8 2534.4
利息收入（費用），非經營淨值 -19.6 328.8 139.1 88.1 13.7
其他，淨值 139.5 50.2 94.7 131.2 5.4
稅前淨收入 4858.8 9325.8 3810.4 2429.1 2553.5
稅後淨收入 4338.4 8075.3 3513.2 2115.8 2376.4
未計算非常項目前的淨收益 4338.4 8075.3 3513.2 2115.8 2376.4
淨收入 4338.4 8075.3 3513.2 2115.8 2444.4
普通股股東可獲收益 (不含非經常性項目) 4338.4 8075.3 3513.2 2115.8 2376.4
普通股股東可獲收益 (含非經常性項目) 4338.4 8075.3 3513.2 2115.8 2444.4
攤薄調整
攤薄淨收入 4338.4 8075.3 3513.2 2115.8 2444.4
攤薄後加權平均股 113.5 112.2 115.1 114.6 114.8
扣除特別項目的每股攤薄盈利 38.2238 71.9724 30.523 18.4625 20.7003
Dividends per Share - Common Stock Primary Issue
每股正常攤薄盈利 40.4714 71.9724 30.523 18.4625 20.7003
非常規項目總計 68
Other Operating Expenses, Total -89.9 -45.6 -280.4
異常費用（收入） 255.1
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
總收入 3414.4 2936.2 2857.2 2965.1 4951.7
收入 3414.4 2936.2 2857.2 2965.1 4951.7
收入成本，共計 540.6 317.8 297.1 404.9 982.6
毛利 2873.8 2618.4 2560.1 2560.2 3969.1
總營業費用 2267.6 1712.5 1747.3 1706.6 2312
銷售/一般/行政費用，總計 660.5 529.1 476.3 450 559.6
研究與開發 1043.1 911.3 794.3 843.8 785.6
Other Operating Expenses, Total -6.6 -45.7 -17.4 -20.2 -15.8
營業收入 1146.8 1223.7 1109.9 1258.5 2639.7
利息收入（費用），非經營淨值 143 239 -176.8 -224.8 -151.8
其他，淨值 34.9 47.1 30.1 27.4 15.5
稅前淨收入 1324.7 1509.8 963.2 1061.1 2503.4
稅後淨收入 1197.1 1315.7 852.1 973.5 2229
未計算非常項目前的淨收益 1197.1 1315.7 852.1 973.5 2229
淨收入 1197.1 1315.7 852.1 973.5 2229
普通股股東可獲收益 (不含非經常性項目) 1197.1 1315.7 852.1 973.5 2229
普通股股東可獲收益 (含非經常性項目) 1197.1 1315.7 852.1 973.5 2229
攤薄淨收入 1197.1 1315.7 852.1 973.5 2229
攤薄後加權平均股 114.1 112.8 114 113.1 113.4
扣除特別項目的每股攤薄盈利 10.4917 11.664 7.47456 8.60743 19.6561
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 10.7546 11.664 9.20263 8.85588 19.6561
異常費用（收入） 30 0 197 28.1
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 14014.9 9779.1 7689.1 6447.6 4335.03
現金和短期投資 5694.7 3587 3214.3 2809.9 1409.58
現金等價物 2885.6 2193.7 1617.8 1467.7 812.733
短期投資 2809.1 1393.3 1596.5 1342.2 596.847
應收賬款總額，淨額 6036.5 4114.7 2672.2 2243.2 1974.34
Accounts Receivable - Trade, Net 6036.5 4114.7 2672.2 2243.2 1974.34
Total Inventory 1502.8 1485.7 1014.6 822.3 513.878
Prepaid Expenses 332.4 160.8 387.1 243.3 224.972
Other Current Assets, Total 448.5 430.9 400.9 328.9 212.26
Total Assets 25434.8 17163.3 14805.2 11734.5 8764.29
Property/Plant/Equipment, Total - Net 3482.2 3221.6 2890.4 2575.8 2358.6
Property/Plant/Equipment, Total - Gross 4880.3 4352.7 3812.8 3304.5 2924.9
Accumulated Depreciation, Total -1398.1 -1131.1 -922.4 -728.7 -566.294
Long Term Investments 6878 3194.8 3312.4 1800.5 1486.49
Other Long Term Assets, Total 1059.7 967.8 913.3 910.6 584.157
Total Current Liabilities 3932.5 2697.4 2096.6 1442.8 1135.48
Accounts Payable 564 475.5 418.1 218.2 178.183
Accrued Expenses 1880.5 1502.3 1037.4 751.3 636.668
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 719.7 0
Other Current Liabilities, Total 768.3 719.6 641.1 473.3 320.632
Total Liabilities 6666 6138 3715.5 2977.2 2620.21
Total Long Term Debt 1980 2695.7 713.9 708.5 703.453
Capital Lease Obligations 0 717.2 713.9 708.5 703.453
Other Liabilities, Total 753.5 744.9 905 825.9 781.272
Total Equity 18768.8 11025.3 11089.7 8757.3 6144.08
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.1 0.1 0.1 0.1 0.112
Additional Paid-In Capital 8087.5 6716.2 4428.6 3911.6 3512.83
Retained Earnings (Accumulated Deficit) 18968.3 10893 7379.8 5254.3 2946.73
Treasury Stock - Common -8260.9 -6613.3 -739.9 -396.4 -316.24
Other Equity, Total -26.2 29.3 21.1 -12.3 0.64
Total Liabilities & Shareholders’ Equity 25434.8 17163.3 14805.2 11734.5 8764.29
Total Common Shares Outstanding 108.675 106.951 110.277 109.006 107.625
Long Term Debt 1980 1978.5
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 14306 14014.9 13775.4 13337.6 10055.1
現金和短期投資 7050.6 5694.7 5787.6 3910.8 3503.8
現金等價物 3345.7 2885.6 3432.4 2072.2 1437.9
短期投資 3704.9 2809.1 2355.2 1838.6 2065.9
應收賬款總額，淨額 4839 6036.5 5452 6998.6 4173
Accounts Receivable - Trade, Net 4839 6036.5 5452 6998.6 4173
Total Inventory 1465.7 1502.8 1550.1 1448.9 1665.3
Prepaid Expenses 424.9 332.4 482 444.3 213.6
Other Current Assets, Total 525.8 448.5 503.7 535 499.4
Total Assets 26348.7 25434.8 23671.5 21485.9 17772.2
Property/Plant/Equipment, Total - Net 3556.4 3482.2 3395.7 3358.5 3262.6
Long Term Investments 7130.7 6878 5671.3 3940.3 3583.7
Other Long Term Assets, Total 1355.6 1059.7 829.1 849.5 870.8
Total Current Liabilities 3007.6 3932.5 3714.8 3732.4 3217.8
Accounts Payable 470.3 564 427 476 542.9
Accrued Expenses 2046 2206.8 2061 2018 1492.2
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 719.7 719 718.4 717.8
Other Current Liabilities, Total 491.3 442 507.8 520 464.9
Total Liabilities 6434 6666 6413.5 6358.6 5795.2
Total Long Term Debt 2700.4 1980 1979.6 1979.2 1978.9
Long Term Debt 1980.4 1980 1979.6 1979.2 1978.9
Capital Lease Obligations 720 0 0 0 0
Other Liabilities, Total 726 753.5 719.1 647 598.5
Total Equity 19914.7 18768.8 17258 15127.3 11977
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.1 0.1 0.1 0.1 0.1
Additional Paid-In Capital 8754.1 8087.5 7919.3 7225.8 6887.8
Retained Earnings (Accumulated Deficit) 19941.8 18968.3 16739.3 15107.1 12008.2
Treasury Stock - Common -8611.2 -8260.9 -7410.2 -7221.4 -6935.3
Other Equity, Total -170.1 -26.2 9.5 15.7 16.2
Total Liabilities & Shareholders’ Equity 26348.7 25434.8 23671.5 21485.9 17772.2
Total Common Shares Outstanding 109.507 108.675 108.527 106.72 106.644
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 8075.3 3513.2 2115.8 2444.4 1198.51
經營活動産生的現金 7081.3 2618.1 2430 2195.1 1307.11
經營活動産生的現金 286.2 235.9 210.3 148.2 145.467
Deferred Taxes -147.1 75.6 -130.6 -140 318.809
非現金物品 783.4 297 435 439.5 570.858
Cash Taxes Paid 1218.4 188.1 342.3 205.6 754.843
已付現金利息 55.8 23.2 25 22.3 18.678
營運資金的變化 -1916.5 -1503.6 -200.5 -697 -926.533
投資活動産生的現金 -5384.7 -70.6 -2027.8 -1463 -1005.18
資本支出 -551.9 -614.6 -429.6 -383.1 -272.626
其他投資現金流量項目，總計 -4832.8 544 -1598.2 -1079.9 -732.556
融資活動産生的現金 -1005.8 -1970.5 -252.1 -77.1 -24.4
融資現金流項目 -1032.7 -680.8 -188 -187.2 -301.688
股票的發行（報廢），淨額 26.9 -3271.6 -64.1 110.1 240.213
債務的發行（退還），淨額 0 1981.9 0 37.075
現金淨變化 690.8 577 150.1 655 277.53
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 973.5 8075.3 5846.3 4214.1 1115.2
Cash From Operating Activities 2101.7 7081.3 4708.8 1295.2 668.5
Cash From Operating Activities 74.3 286.2 211.7 138.5 67.4
Deferred Taxes -225 -147.1 58.8 51.8 10.1
Non-Cash Items 455.7 783.4 153.1 -84.9 15.2
Changes in Working Capital 823.2 -1916.5 -1561.1 -3024.3 -539.4
Cash From Investing Activities -1705.3 -5384.7 -3372 -933.2 -1059
Capital Expenditures -141.8 -551.9 -397 -263.8 -115.3
Other Investing Cash Flow Items, Total -1563.5 -4832.8 -2975 -669.4 -943.7
Cash From Financing Activities 64.7 -1005.8 -99.2 -484.6 -366.4
Financing Cash Flow Items -98.8 -1032.7 -450.3 -180.7 -154.5
Issuance (Retirement) of Stock, Net 163.5 26.9 351.1 -303.9 -211.9
Net Change in Cash 461.1 690.8 1237.6 -122.6 -756.9
Issuance (Retirement) of Debt, Net 0 0 0
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Fidelity Management & Research Company LLC Investment Advisor 9.914 10658247 268103 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.0656 8671077 74457 2022-12-31 LOW
Capital World Investors Investment Advisor 5.8065 6242435 16836 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.7272 6157131 -211997 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.6145 4960885 -90874 2022-12-31 LOW
JP Morgan Asset Management Investment Advisor 4.4213 4753254 301869 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.2475 2416247 -27042 2022-12-31 LOW
Dodge & Cox Investment Advisor/Hedge Fund 2.0678 2223059 -63450 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0538 2207990 -32123 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.4723 1582798 -28736 2022-12-31 LOW
Capital International Investors Investment Advisor 1.4231 1529943 -237193 2022-12-31 LOW
Invesco Capital Management (QQQ Trust) Investment Advisor 1.2962 1393537 7205 2023-02-28 LOW
Loomis, Sayles & Company, L.P. Investment Advisor/Hedge Fund 1.2443 1337681 -378936 2022-12-31 LOW
Yancopoulos (George D) Individual Investor 1.1527 1239194 -79973 2022-04-12 LOW
Putnam Investment Management, L.L.C. Investment Advisor/Hedge Fund 1.0395 1117533 13700 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.025 1102002 -76069 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.899 966467 1776 2022-12-31 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.7992 859202 -22201 2022-12-31 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7733 831369 -41616 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7213 775449 -12042 2022-12-31 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

777 Old Saw Mill River Road
TARRYTOWN
NEW YORK 10591
US

收入報表

  • Annual
  • Quarterly

人們也觀看

Oil - Crude

72.90 Price
-0.960% 1D Chg, %
多頭倉位隔夜費用 -0.0162%
空頭倉位隔夜費用 -0.0057%
隔夜費時間 21:00 (UTC)
價差 0.03

Gold

1,963.89 Price
-0.500% 1D Chg, %
多頭倉位隔夜費用 -0.0087%
空頭倉位隔夜費用 0.0005%
隔夜費時間 21:00 (UTC)
價差 0.33

US100

12,833.20 Price
+1.630% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 1.8

XRP/USD

0.55 Price
+3.730% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00500

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易